Extrapulmonary small cell carcinoma: An indication for prophylactic cranial irradiation? A single center experience

Strahlentherapie und Onkologie

Volumn 187, Issue 9, 2011, Pages 561-567

  Früh, Martin ^a   Kacsir, Bela ^b   Ess, Silvia ^c   Cerny, Thomas ^a   Rodriguez, Regulo ^b   Plasswilm, Ludwig ^b  

^a Fachbereich Onkologie/Hamatologie   (Switzerland)

^b CANTONAL HOSPITAL ST GALLEN   (Switzerland)

^c Canton of St Gallen/Appenzell ^*  (Switzerland)

Author keywords

Extrapulmonary; Prophylactic cranial irradiation; Small cell carcinoma

Indexed keywords

ETOPOSIDE;

ADULT; AGED; ARTICLE; BRAIN METASTASIS; CLINICAL ARTICLE; FEMALE; FEMALE GENITAL TRACT TUMOR; GASTROINTESTINAL TUMOR; HEAD AND NECK TUMOR; HUMAN; LUNG SMALL CELL CANCER; MALE; OUTCOME ASSESSMENT; PRIMARY TUMOR; PROPHYLAXIS; RADIOTHERAPY; SKULL IRRADIATION; SURVIVAL; UROGENITAL TRACT TUMOR; WEIGHT REDUCTION;

ADULT; AGED; AGED, 80 AND OVER; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; BRAIN NEOPLASMS; CARCINOMA, SQUAMOUS CELL; COMBINED MODALITY THERAPY; CRANIAL IRRADIATION; DISEASE-FREE SURVIVAL; FEMALE; HUMANS; MALE; MIDDLE AGED; NEOADJUVANT THERAPY; NEOPLASM STAGING; RETROSPECTIVE STUDIES;

EID: 80755139762     PISSN: 01797158     EISSN: 1439099X     Source Type: Journal    
DOI: 10.1007/s00066-011-2222-x     Document Type: Article

References (49)

1. Argiris A, Murren JR. Staging and clinical prognostic factors for small-cell lung cancer. Cancer J 2001;7:437-47.
2. Aupérin A, Arriagada R, Pignon JP et al. Prophylactic cranial irradiation for patients with small-cell lung cancer in complete remission. Prophylactic Cranial Irradiation Overview Collaborative Group. N Engl J Med 1999;341:476-84. (Pubitemid 29372887)
3. Brambilla E, Travis WD, Colby TV et al. The new World Health Organization classification of lung tumours. Eur Respir J 2001;18:1059-68. (Pubitemid 34092881)
4. Brennan SM, Gregory DL Stillie A et al. Should extrapulmonary small cell cancer be managed like small cell lung cancer? Cancer 2010;116:888-95.
5. Brenner B, Tang LH, Klimstra DS et al. Small-cell carcinoma of the gastrointestinal tract: a review. J Clin Oncol 2004;22:2730-9. (Pubitemid 41103762)
6. Chionh F, Azad A, Lee C. Small cell carcinoma of unknown primary presenting with disease confined to the central nervous system. Acta Oncol 2009;48:317-8.
7. Eckert F, Fehm T, Bamberg M et al. Small cell carcinoma of vulva: curative multimodal treatment in face of resistance to initial standard chemotherapy. Strahlenther Onkol 2010;186:521-4.
8. Fisher ER, Palekar A, Paulson JD. Comparative pathologic, histochemical, electron microscopic, and tissue culture studies of bronchial carcinoids and oat cell carcinoma of the lung. Am J Clin Pathol 1978;69:165-72. (Pubitemid 8299136)
9. Frazier SR, Kaplan PA, Loy TS. The pathology of extrapulmonary small cell carcinoma. Semin Oncol 2007;34:30-8. (Pubitemid 46161763)
10. Galanis E, Frytak S, Lloyd RV. Extrapulmonary small cell carcinoma. Cancer 1997;79:1729-36. (Pubitemid 27176355)
11. Giddings NA, Kennedy TL, Vrabec DP. Primary small cell carcinoma of the larynx: analysis of treatment. J Otolaryngol 1987;16:157-66. (Pubitemid 17092866)
12. Gregor A, Drings P, Burghouts J et al. Randomized trial of alternating versus sequential radiotherapy/chemotherapy in limited-disease patients with small-cell lung cancer: A European Organization for Research and Treatment of Cancer Lung Cancer Cooperative Group study. J Clin Oncol 1997;15:2840-9. (Pubitemid 27330011)
13. Haider K, Shahid RK, Finch D et al. Extrapulmonary small cell cancer: a Canadian province's experience. Cancer 2006;107:2262-9. (Pubitemid 44665662)
14. Hainsworth JD, Johnson DH, Greco FA. Poorly differentiated neuroendocrine carcinoma of unknown primary site. A newly recognized clinicopathologic entity. Ann Intern Med 1988;109:364-371.
15. Henricus FM, Yvonne F. Extrapulmonary small cell carcinoma. South Med J 2005;98:345-9.
16. Hochstenbag MMH, Twijnstra A, Wilmink JT et al. Asymptomatic brain metastases (BM) in small cell lung cancer: MR-imaging is useful at initial diagnosis. J Neurooncol 2000;48:243-8.
17. Kim JH, Lee SH, Park J et al. Extrapulmonary small cell carcinoma: a singleinstitution experience. Jpn J Clin Oncol 2004;34:250-4.
18. Lammering G, De Ruysscher D, van Baardwijk A et al. The use of FDG-PET to target tumors by radiotherapy. Strahlenther Onkol 2010;186:471-81.
19. Lee SS, Lee JL, Ryu MH et al. Extrapulmonary small cell carcinoma: single center experience with 61 patients. Acta Oncol 2007;46:846-51. (Pubitemid 47123777)
20. Levenson RM, Ihde DC, Matthews MJ et al. Small cell carcinoma presenting extrapulmonary neoplasm: site of origin and response to chemotherapy. J Natl Cancer Inst 1981;67:607-12. (Pubitemid 11050932)
21. Lo Re G, Canzonieri V, Veronesi A et al. Extrapulmonary small cell carcinoma: a single institution experience and review of the literature. Ann Oncol 1994;5:909-13.
22. Miller AB, Hoogstraten B, Staquet M et al. Reporting results of cancer treatment. Cancer 1981;47:207-14. (Pubitemid 11167383)
23. Mirri MA, Arcangeli G, Benassi M, et al. Hypofractionated conformal radiotherapy (HCRT) for primary and metastatic lung cancers with small dimension: efficacy and toxicity. Strahlenther Onkol 2009;185:27-33.
24. Mukesh M, Cook N, Hollingdale AE et al. Small cell carcinoma of the urinary bladder: a 15-year retrospective review of treatment and survival in the Anglian Cancer Network. BJU Int 2009;103:747-52.
25. Navneet SM, Paul E, Ronald MB. Therapy and outcome of small cell carcinoma of the kidney. Report of two cases and a systematic review of the literature. Cancer 2003;97:1436-41.
26. Nugent JL, Bunn PA Jr, Matthews MJ et al. CNS metastases in small cell bronchogenic carcinoma: increasing frequency and changing pattern with lengthening survival. Cancer 1979;44:1885-93. (Pubitemid 10141970)
27. Ochsenreither S, Marnitz-Schultze S, Schneider A et al. Extrapulmonary small cell carcinoma (EPSCC): 10 years' multi-disciplinary experience at Charité. Anticancer Res 2009;29:3411-5.
28. Pearse AGE, Takor TT. Neuroendocrine embryology and the APUD concept. Clin Endocrinol 1976;5:229-44.
29. Perry MC, Herndon JE III, Eaton WL et al. Thoracic radiation therapy added to chemotherapy for small-cell lung cancer: an update of Cancer and Leukemia Group B study 8083. J Clin Oncol 1998;16:2466-7. (Pubitemid 28309042)
30. Remick SC, Hafez GR, Carbone PP et al. Extrapulmonary small-cell carcinoma: a review of the literature with emphasis on therapy and outcome. Medicine (Baltimore) 1987;66:457-71. (Pubitemid 18008935)
31. Remick SC, Ruckdeschel JC. Extrapulmonary and pulmonary small-cell carcinoma: tumor biology, therapy and outcome. Med Pediatr Oncol 1992;20:89-99.
32. Richardson RL, Weiland LH. Undifferentiated small cell carcinoma in extrapulmonary sites. Semin Oncol 1982;9:484-96. (Pubitemid 13146159)
33. Satoh H, Ishikaua H, Ohtsuka M et al. Small cell carcinoma of the pleura. Soth Med J 2002;95:1221. (Pubitemid 35244849)
34. Schild SE, Bonner JA, Shanahan TG et al. Long-term results of a phase III trial comparing once-daily radiotherapy with twice-daily radiotherapy in limited-stage small-cell lung cancer. Int J Radiat Onol Biol Phys 2004;59:943-51. (Pubitemid 38834286)
35. Sengoz M, Abacioglu U, Turhal S et al. Extrapolmonary small cell carcinoma: multimodality treatment results. Tumori 2003;89:274-7. (Pubitemid 37014118)
36. Shahab N, Mirza IA, Doll D. Extrapulmonary small cell carcinoma. Semin Oncol 2007;34:1-2. (Pubitemid 46201665)
37. Siefker-Radtke AO, Kamat AM, Grossman HB et al. Phase II clinical trial of neoadjuvant alternating doublet chemotherapy with ifosfamide/doxorubicin and etoposide/cisplatin in small-cell urothelial cancer. J Clin Oncol 2009;27:2592-7.
38. Skarlos DV, Samantas E, Briassoulis E et al. Randomized comparison of early versus late hyperfractionated thoracic irradiation concurrently with chemotherapy in limited disease small-cell lung cancer: a randomized phase II study of the Hellenic Cooperative Oncology Group (HeCOG). Ann Oncol 2001;12:1231-8. (Pubitemid 32994750)
39. Slotman B, Faivre-Finn C, Kramer G et al. Prophylactic cranial irradiation in extensive small-cell lung cancer. N Engl J Med 2007;357:664-72. (Pubitemid 47267236)
40. Soto DE, Eisbruch A. Limited-stage extrapulmonary small cell carcinoma: outcomes after modern chemotherapy and radiopherapy. The Cancer J 2007;13:4.
41. Stahel RA, Ginsberg R, Havemann K et al. Staging and prognostic factors in small cell lung cancer: a consensus report. Lung Cancer 1989;5:119-26. (Pubitemid 20053516)
42. Therasse P, Arbuck SG, Eisenhauer EA et al. New guidelines to evaluate the response to treatment in solid tumors. European Organization for Research and Treatment of Cancer, National Cancer Institute of the United States, National Cancer Institute of Canada. J Natl Cancer Inst 2000;92:205-16.
43. Travis WD, Colby TV, Corrin B et al. Histological typing of lung and pleural tumours; World Health Organization International Histological Classification of Tumours. Berlin, Springer 1999, 3rd Edn.
44. Turrisi AT, Kim K, Blum R et al. Twice-daily compared with one-daily thoracic radiotherapy in limited-stage small cell lung cancer treated concurrently with cisplatin and etoposide. N Engl J Med 1999;340:265-71. (Pubitemid 29063268)
45. Van der Gaast A, Verwey J, Prins E et al. Chemotherapy as treatment of choice in extrapulmonary undifferentiated small cell carcinomas. Cancer 1990;65:422-4.
46. Viswanathan AN, Deavers MT, Jhingran A et al. Small cell neuroendocrine carcinoma of the cervix: outcome and patterns of recurrence. Gynecol Oncol 2004;93:27-33. (Pubitemid 38429545)
47. Vrouvas J, Ash DV. Extrapulmonary small cell cancer. Clin Oncol (R Coll Radiol) 1995;7:377-81.
48. Walenkamp AM, Sonke GS, Sleijfer DT. Clinical and therapeutic aspects of extrapulmonary small cell carcinoma. Cancer Treat Rev 2009;35:228-36.
49. Wurstbauer K, Weise H, Deutschmann H et al. Non-small cell lung cancer in stages I-IIIB: long-term results of definitive radiotherapy with doses = 80 Gy in standard fractionation. Strahlenther Onkol 2010;186:551-7.